KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Shares Outstanding (2016 - 2022)

Palvella Therapeutics (PVLA) has disclosed Shares Outstanding for 11 consecutive years, with $1.8 million as the latest value for Q3 2024.

  • On a quarterly basis, Shares Outstanding rose 43.22% to $1.8 million in Q3 2024 year-over-year; TTM through Sep 2024 was $1.8 million, a 43.22% increase, with the full-year FY2023 number at $1.8 million, up 90.14% from a year prior.
  • Shares Outstanding was $1.8 million for Q3 2024 at Palvella Therapeutics, roughly flat from $1.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $74.4 million in Q3 2022 to a low of $11000.0 in Q1 2020.
  • A 5-year average of $26.2 million and a median of $1.8 million in 2022 define the central range for Shares Outstanding.
  • Biggest YoY gain for Shares Outstanding was 699537.5% in 2020; the steepest drop was 99.98% in 2020.
  • Palvella Therapeutics' Shares Outstanding stood at $56.0 million in 2020, then crashed by 99.97% to $16000.0 in 2021, then skyrocketed by 10963.54% to $1.8 million in 2022, then changed by 0.0% to $1.8 million in 2023, then changed by 0.0% to $1.8 million in 2024.
  • Per Business Quant, the three most recent readings for PVLA's Shares Outstanding are $1.8 million (Q3 2024), $16000.0 (Q2 2024), and $1.8 million (Q1 2024).